CHATSWORTH, Calif., Feb. 13, 2012 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS - News), a leading manufacturer of automated in-vitro diagnostics systems and consumables, and a developer of high-value personalized diagnostics tests, today announced that its Sample Processing division has signed an agreement with Fisher HealthCare, part of Thermo Fisher Scientific Inc. (NYSE:TMO - News), as its first commercial distribution partner for the new ThermoBrite Elite instrument for automated FISH (fluorescence in situ hybridization) sample preparation.
